Sinil Pharmaceutical Co Ltd
KOSDAQ:012790
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Apple Inc
XMUN:APC
|
US |
Sinil Pharmaceutical Co Ltd
Inventory
Sinil Pharmaceutical Co Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Sinil Pharmaceutical Co Ltd
KOSDAQ:012790
|
Inventory
₩24B
|
CAGR 3-Years
9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
10%
|
|
|
Yuhan Corp
KRX:000100
|
Inventory
₩372.8B
|
CAGR 3-Years
11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
4%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Inventory
₩100.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Inventory
₩338.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Inventory
₩47.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Inventory
₩22.7B
|
CAGR 3-Years
41%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Sinil Pharmaceutical Co Ltd
Glance View
Sinil Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products. The company is headquartered in Chungju, Chungcheongbuk-Do. The Company’s products consist of antihyperlipidemic agents, antitussives, expectorants, anti-antipyretic agents, analgesic agents, inflammatory agents, dermatological treatments, chemotherapeutic agents, antihistamines, antihypertensives and mixed vitamins, among others. The company also engages in the leasing of real estate.
See Also
What is Sinil Pharmaceutical Co Ltd's Inventory?
Inventory
24B
KRW
Based on the financial report for Sep 30, 2025, Sinil Pharmaceutical Co Ltd's Inventory amounts to 24B KRW.
What is Sinil Pharmaceutical Co Ltd's Inventory growth rate?
Inventory CAGR 10Y
10%
Over the last year, the Inventory growth was 11%. The average annual Inventory growth rates for Sinil Pharmaceutical Co Ltd have been 9% over the past three years , 5% over the past five years , and 10% over the past ten years .
